Ergomed is delighted to welcome Debra Kientop as the new Vice President of Therapeutic Strategy for Oncology.
Debra is an experienced, strategic leader in oncology clinical development across Pharma, Biotech, and CRO industries. She has a consultative and collaborative approach to strategic development, focusing on patient-centricity and incorporating innovative solutions into clinical delivery. Her experience places Ergomed in a solid position to enhance its oncology business further.
Debra shared: “I am excited to be part of expanding Ergomed’s oncology business. I look forward to strengthening our partnerships with clients, research sites, and technology providers to bring clinical trials to patients.”
As a cancer survivor and advocate, Debra is always thinking about patients and how we can work with our sponsors to develop strategies that meet the needs of all stakeholders.
Please, join us in wishing Debra the very best in her new role!
If you require further information, please do not hesitate to contact us.